Transcriptional effects of superinfection in HIV chronically infected T cells: Studies in dually infected clones

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 4, 1996, Pages 329-342

  Kim, Jerome H ^a,c   McLinden, Robert J ^b   Mosca, Joseph D ^b   Burke, Donald S ^a   Boswell, R Neal ^a   Birx, Deborah L ^a   Redfield, Robert R ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

Dual infection; HIV 1 superinfection; Transcription HIV 1

Indexed keywords

NEOMYCIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CHRONIC DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SUPERINFECTION; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS INTERFERENCE; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029831330     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608010-00002     Document Type: Article

References (35)

1. Rubin H. A virus in chick embryos which induces resistance in vitro to infection with Rous sarcoma virus. Proc Natl Acad Sci USA 1960;46:1105-19.
2. Sommerfelt MA, Weiss RA. Receptor interference groups of 20 retroviruses plating on human cells. Virology 1990;176: 58-69.
3. Steck FT, Rubin H. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology 1966;29:628-41.
4. Steck FT, Rubin H. The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. II. Early steps of infection by RSV of cells under conditions of interference. Virology 1966;29:642-53.
5. Vogt PK, Ishizaki R. Patterns of viral interference in the avian leukosis and sarcoma complex. Virology 1966;30:368-74.
6. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-7.
7. Stevenson M, Zhang X, Volsky DJ. Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol 1987;61: 3741-8.
8. Hart AR, Cloyd MW. Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2. Virology 1990;177: 1-10.
9. + cells: mechanism for persistence in AIDS. Cell 1988;53:483-96.
10. Pauza CD, Galindo JE, Richman DD. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med 1990;172:1035-42.
11. Kim S, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol 1989;63:3708-13.
12. Robinson HL, Zinkus DM. Accumulation of human immunodeficiency virus type 1 DNA in T cells: result of multiple infection events. J Virol 1990;64:4836-41.
13. Besansky NJ, Butera ST, Sinha S, Folks TM. Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression. J Virol 1991;65:2695-8.
14. Le Guern M, Levy JA. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-1-infected cells: pseudotype virions produced with expanded cellular host range. Proc Natl Acad Sci USA 1992;89:363-7.
15. Yunoki M, Maotani-Imai K, Kusuda H, et al. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Arch Virol 1991;116:143-58.
16. Kim JH, Mosca JD, Vahey MT, McLinden RJ, Burke DS, Redfield RR. Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells. AIDS Res Hum Retroviruses 1993;9:875-82.
17. Winslow BJ, Pomerantz RJ, Bagasra O, Trono D. HIV-1 latency due to the site of proviral integration. Virology 1993; 196:849-54.
18. Folks T, Powell DM, Lightfoote MM, Benn S, Martin MA, Fauci AS. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science 1986; 231:600-2.
19. Kim JH, Ratto S, Sitz KV, Mosca JD, et al. Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T-cells. Hum Gene Ther 1994;5:1457-66.
20. Mosca JD, Kaushal S, Gartner SG, et al. Characterization of a human stromal cell line supporting hematopoietic stem cell proliferation and the effect of HIV expression. J Biomed Sci (in press).
21. Bednarik DP, Mosca JD, Raj NBK. Methylation as a modulator of expression of human immunodeficiency virus. J Virol 1987;61:1253-7.
22. Chen BK, Saksela K, Andino R, Baltimore D. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J Virol 1994;68:654-60.
23. Bird A. The essentials of DNA methylation. Cell 1992;70: 5-8.
24. Arya SK, Guo C, Josephs SF, Wong-Staal F. Transactivation gene of human T-lymphotropic virus type III (HTLV-III). Science 1985;229:69-73.
25. Sodroski J, Patarca R, Wong C, Wong-Staal F, Haseltine W. Location of trans-activator region on genome of human T-cell lymphotropic virus type III. Science 1985;229:74-7.
26. Muesing MA, Smith DH, Capon DJ. Regulation of mRNA accumulation by a human immunodeficiency virus transactivator protein. Cell 1987;48:691-701.
27. Seigel LJ, Ratner L, Josephs SF, et al. Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology 1986;148:226-31.
28. Jeang K-T, Berkhout B, Dropulic B. Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 1993;268:24940-9.
29. Tong-Starksen SE, Baur A, Lu X-B, Peck-E, Peterlin BM. Second exon of Tat of HIV-2 is required for optimal transactivation of HIV-1 and HIV-2 LTRs. Virology 1993;195: 826-30.
30. Howcroft TK, Strebel K, Martin MA, Singer DS. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 1993;260:1320-2.
31. Butera ST, Roberts BD, Lam L, Hodge T, Folks TM. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol 1994;68:2726-30.
32. Biswas P, Smith CA, Goletti D, Hardy EC, Jackson RW, Fauci AS. Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 1995;2:587-96.
33. Cannon P, Kim S-H, Ulich C, Kim S. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J Virol 1994;68: 1993-7.
34. Sabino EC, Shpaer EG, Morgado MG, et al. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994;68:6340-6.
35. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995;171:805-10.